Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic LeukemiaMichael J. Keating, Hagop M. Kantarjian, Stefan Faderl et al.|Journal of Clinical Oncology|2005Cited by 951
Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemiaAlessandra Ferrajoli, George A. Călin, Tait D. Shanafelt et al.|Blood|2013Cited by 220
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemiaWilliam G. Wierda, Maher Albitar, Marcella M. Johnson et al.|British Journal of Haematology|2003Cited by 80
Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemiaXavier C. Badoux, William G. Wierda, Michael J. Keating et al.|Blood|2011Cited by 63